Stockreport

HERVolution Appoints Dr. Tine Gaziel as CMO to Advance Dark Genome-Targeting Immune Therapy into the Clinic [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF In her new role, she will oversee the regulatory and clinical development of the company's novel HERV-targeting pipeline; including plans to enter the clinic with lead [Read more]